Summary
Overview
Work History
Education
Skills
Languages
Interests
Timeline
Generic

David Radford

Summary

Experienced with strategic leadership, harnessing deep understanding of market dynamics to drive organizational growth. Utilises analytical thinking and vision to develop and implement growth strategies. Track record of fostering innovation and leading high-impact teams to achieve business objectives.

Overview

27
27
years of professional experience

Work History

Consultant to Private Equity

Lucremont P/L
05.2013 - Current
  • Introduction of investment opportunities to private equity funds
  • Development of a major acquisition plan in healthcare in partnership with an international deal originator
  • Developed key operational initiatives to drive and maintain substantial business growth.
  • Established new revenue streams by identifying market opportunities and launching innovative products or services.
  • Ongoing advisory role to multiple PE firms

CEO & Managing Director

Anteotech Ltd
09.2022 - 04.2025
  • Restructure of business to focus upon core capabilities-requiring significant changes both culturally and structurally
  • Commenced commercialisation activities having changed culture from “scientist run” to a “market led-sales driven” culture, including creation of a commercially focused leadership team
  • Built productive relationships with industry partners to support strategic business objectives, including Mercedes Benz and Serum Institute of India
  • Developed a high-performance executive team for improved productivity and efficiency.
  • Ensured regulatory compliance by developing robust policies, procedures, and internal controls.
  • Cultivated forward-thinking, inclusive, and performance-oriented business culture to lead industry in innovation and push progress.
  • Directed launch of innovative products, to capture new market segments and drive revenue growth.



CEO

Allvascular Limited
08.2018 - 09.2022
  • Development of a strategic plan to build a Company with the capability to raise capital and prepare for a future IPO
  • Capital raised from investors and NSW Health to enable commercialisation commencement
  • Changed the focus from a family owned business to professional business with capability to execute on the strategic plan
  • Initial sales into Australia, with distribution channel in EU established (Spain/UK/Germany)
  • Increased visibility and reputation within the market segments AVL operates-resulting in a sale of the business in 2023

CHIEF EXECUTIVE OFFICER-Consulting role

The Hydroponics Company (ASX:THC)
08.2017 - 04.2018
  • Development of the Company’s strategic plan to competitively position the Company in a new and rapidly growing global market.
  • Established foundational processes for business operations.
  • Identified new revenue generation opportunities to maximize bottom-line profitability.
  • Built productive relationships with industry partners and competitors resulting in >50% organic growth
  • Implemented strong financial controls, ensuring accurate reporting and solid decision-making capabilities.
  • Updated business processes, products, and team makeups to generate more business opportunities and cater to market needs
  • Increased market capitalization from AUD19m to >AUD100m
  • Increased the number of institutional investors from 1 to 8 on a capital raise

CHIEF EXECUTIVE OFFICER & DIRECTOR

Obex Medical Holdings P/L
09.2014 - 08.2017
  • Developed and executed an acquisition plan using Obex Medical Limited (NZ) as a platform for an Australasian roll up opportunity in conjunction with The Growth Fund (previously Archer Growth)
  • Acquisition of a bolt-on business in NZ and addition of several significant agencies to Obex’s portfolio
  • Achievement of >20% growth in a mature market for medical consumables through implementation of Best Sales Practices and relevant KPI tracking and monitoring driving operational initiatives
  • Identification of an extensive pipeline of acquisition opportunities across ANZ

Managing Director

Bioxyne Limited (ASX:BXN)
06.2011 - 05.2013

CEO & Executive Director

Nanosonics Limited (ASX:NAN)
06.2008 - 06.2011

General Manager & VP Asia Clinical Systems Service

General Electric (GE)
09.2005 - 04.2008

General Manager & Director

General Electric (GE)
09.2002 - 09.2005

Regional General Manager & Director-Asia & Middle East

Recall Limited (Brambles Australia)
07.2000 - 09.2002

General Manager Healthcare Services

Brambles Australia
08.1998 - 07.2000

Education

Company Directors Course -

Australian Institute of Company Directors

MBA -

AGSM
University Of New South Wales

Bachelor of Science -

University of West of England
Bristol, UK

Skills

  • Targeted business expansion
  • Expert in revenue enhancement
  • Strategic sales leadership
  • Experienced CEO
  • Broad capital markets experience
  • Adept relationship development
  • Empowering team leadership
  • Accountability in plan implementation
  • Strong verbal and written skills

Languages

French
Limited Working

Interests

Mentoring of recent graduates to assist them in their first roles; Music-Subscriber to Sydney Symphony & Opera; Sports-regular golfer and infrequent rower; Travel-cultural awareness and immersion

Timeline

CEO & Managing Director

Anteotech Ltd
09.2022 - 04.2025

CEO

Allvascular Limited
08.2018 - 09.2022

CHIEF EXECUTIVE OFFICER-Consulting role

The Hydroponics Company (ASX:THC)
08.2017 - 04.2018

CHIEF EXECUTIVE OFFICER & DIRECTOR

Obex Medical Holdings P/L
09.2014 - 08.2017

Consultant to Private Equity

Lucremont P/L
05.2013 - Current

Managing Director

Bioxyne Limited (ASX:BXN)
06.2011 - 05.2013

CEO & Executive Director

Nanosonics Limited (ASX:NAN)
06.2008 - 06.2011

General Manager & VP Asia Clinical Systems Service

General Electric (GE)
09.2005 - 04.2008

General Manager & Director

General Electric (GE)
09.2002 - 09.2005

Regional General Manager & Director-Asia & Middle East

Recall Limited (Brambles Australia)
07.2000 - 09.2002

General Manager Healthcare Services

Brambles Australia
08.1998 - 07.2000

Company Directors Course -

Australian Institute of Company Directors

MBA -

AGSM

Bachelor of Science -

University of West of England
David Radford